
|Articles|April 25, 2016
Perrigo Confirms Papa Exit
April 25, 2016.
Advertisement
Following their refusal to comment Friday on "rumors" that CEO Joseph Papa was leaving to head Valeant Pharmaceuticals, Dublin-based Perrigo has today confirmed the rumor's truth in announcing the appointment of John T. Hendrickson as Perrigo's Chief Executive Officer, "effective immediately, following the resignation and departure of Joseph C. Papa".
Hendrickson has served as President of Perrigo since October 2015. He was formerly Executive Vice President, Global Operations & Supply Chain between 2006 and 2015. Meanwhile, Valeant announced today that Papa tis expected to join the company as Chairman and CEO by early May.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5




